Auxly Cannabis Group Inc. (CBWTF)
OTCMKTS: CBWTF · Delayed Price · USD
0.0230
+0.0010 (4.55%)
Jul 2, 2024, 10:32 AM EDT - Market closed

Auxly Cannabis Group Revenue

Auxly Cannabis Group had revenue of 102.35M CAD in the twelve months ending March 31, 2024, with 6.82% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 25.24M CAD with 5.31% year-over-year growth. In the year 2023, Auxly Cannabis Group had annual revenue of 101.08M CAD with 6.99% growth.

Revenue (ttm)
102.35M CAD
Revenue Growth
+6.82%
P/S Ratio
0.38
Revenue / Employee
277,374 CAD
Employees
369
Market Cap
28.50M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023101.08M6.61M6.99%
Dec 31, 202294.47M10.64M12.70%
Dec 31, 202183.83M33.03M65.03%
Dec 31, 202050.80M42.44M508.19%
Dec 31, 20198.35M7.61M1,018.07%
Dec 31, 2018747.00K-630.99K-45.79%
Dec 31, 20171.38M1.15M495.93%
Dec 31, 2016231.23K-25.98K-10.10%
Dec 31, 2015257.21K-17.84K-6.49%
Dec 31, 2014275.05K-95.02K-25.68%
Dec 31, 2013370.07K-2.83K-0.76%
Dec 31, 2012372.90K14.08K3.92%
Dec 31, 2011358.82K2.30K0.64%
Dec 31, 2010356.53K38.64K12.15%
Dec 31, 2009317.89K82.81K35.22%
Dec 31, 2008235.08K39.78K20.37%
Dec 31, 2007195.30K-9.21M-97.92%
Dec 31, 20069.41M1.61M20.60%
Dec 31, 20057.80M3.97M103.52%
Dec 31, 20043.83M2.01M110.29%
Dec 31, 20031.82M214.04K13.30%
Dec 31, 20021.61M-588.42K-26.78%
Dec 31, 20012.20M-407.67K-15.65%
Dec 31, 20002.61M--
Dec 31, 19990--
Nov 30, 19980--
Aug 31, 19971.00--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings